K

Korean Drug Co Ltd
KOSDAQ:014570

Watchlist Manager
Korean Drug Co Ltd
KOSDAQ:014570
Watchlist
Price: 4 235 KRW -1.28% Market Closed
Market Cap: 46.6B KRW

Korean Drug Co Ltd
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Korean Drug Co Ltd
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
K
Korean Drug Co Ltd
KOSDAQ:014570
EPS (Diluted)
â‚©322
CAGR 3-Years
-29%
CAGR 5-Years
-13%
CAGR 10-Years
5%
Yuhan Corp
KRX:000100
EPS (Diluted)
â‚©917
CAGR 3-Years
-4%
CAGR 5-Years
-20%
CAGR 10-Years
-7%
SK Biopharmaceuticals Co Ltd
KRX:326030
EPS (Diluted)
â‚©4.1k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
EPS (Diluted)
â‚©9.2k
CAGR 3-Years
12%
CAGR 5-Years
N/A
CAGR 10-Years
27%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
EPS (Diluted)
-â‚©648
CAGR 3-Years
-29%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Caregen Co Ltd
KOSDAQ:214370
EPS (Diluted)
â‚©582
CAGR 3-Years
-39%
CAGR 5-Years
-30%
CAGR 10-Years
N/A
No Stocks Found

Korean Drug Co Ltd
Glance View

Market Cap
45.8B KRW
Industry
Pharmaceuticals

KOREAN DRUG Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. The company is headquartered in Icheon, Gyeonggi-Do and currently employs 256 full-time employees. The company went IPO on 2000-12-07. The Company’s products portfolio consists of over-the-counter (OTC) medicines, ethical (ETC) medicines and health food, including multi-symptom cold medicines, blood-forming nutrients, treatments for central nervous system, remedies for respiratory diseases, dermatological agents, vitamins, antifungal agents, antipyretics, analgesics, anti-inflammatory drugs, antibiotics, allergic treatments, calcium and vitamin D tablets and home pregnancy test kits, among others.

Intrinsic Value
4 301.19 KRW
Undervaluation 2%
Intrinsic Value
Price
K

See Also

What is Korean Drug Co Ltd's EPS (Diluted)?
EPS (Diluted)
322.6 KRW

Based on the financial report for Jun 30, 2025, Korean Drug Co Ltd's EPS (Diluted) amounts to 322.6 KRW.

What is Korean Drug Co Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
5%

The average annual EPS (Diluted) growth rates for Korean Drug Co Ltd have been -29% over the past three years , -13% over the past five years , and 5% over the past ten years .

Back to Top